Robert Létienne

Sodium Late Current Blockers in Ischemia Reperfusion: Is the Bullet Magic?

Bruno Le Grand, Christophe Pignier, Robert Létienne et al. · Journal of Medicinal Chemistry · 2008 · 69 citations · Full text

Hypertension, Heart Failure, Ischemia Reperfusion +20

Evidence that ranolazine behaves as a weak β 1 - and β 2 -adrenoceptor antagonist in the rat cardiovascular system

Robert Létienne, Bruno Vié, Aline Puech et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2001 · 55 citations

Molecular Pharmacology, Medicine, Vascular Pharmacology +10

Protease-Activated Receptor-1 Antagonist F 16618 Reduces Arterial Restenosis by Down-Regulation of Tumor Necrosis Factor α and Matrix Metalloproteinase 7 Expression, Migration, and Proliferation of Vascular Smooth Muscle Cells

Pauline Chieng-Yane, Arnaud Bocquet, Robert Létienne et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 44 citations

Discovery of Novel Protease Activated Receptors 1 Antagonists with Potent Antithrombotic Activity in Vivo

Michel Perez, Marie Lamothe, Catherine Maraval et al. · Journal of Medicinal Chemistry · 2009 · 43 citations

Antiplatelet Drugs, Immunology, Pharmacotherapy +18

F 15845 inhibits persistent sodium current in the heart and prevents angina in animal models

Bernard Vacher, Christophe Pignier, Robert Létienne et al. · British Journal of Pharmacology · 2009 · 33 citations · Full text

Cardiac Ischaemia, Cardiac Muscle, Cardiovascular Pharmacology +18